Skip to content

Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology

Home
Uncategorized
Dyne Therapeutics announces $300M proposed public offering

Dyne Therapeutics announces $300M proposed public offering

Dec 8, 2025

Post navigation

Jim Lang Elected to Halozyme’s Board of Directors

Kymera Therapeutics announces $500M proposed public offering

PR Newswire
GlobeNewswire

Contact
Privacy Policy

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Search for: